| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.0073 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |